Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Morice

Showing results (231-240 of 284) with videos related to

Pageof 29
Sort By:
Gynecologic Oncology|January 19, 2017
Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factorsAlexandre Escande, Sebastien Gouy, Renaud Mazeron, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2020
Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patientsJean-Baptiste Delhorme, Jordan Ohayon, Sébastien Gouy, et al.
Plos One|January 29, 2016
Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?Fabien Vidal, Paul Guerby, Mathieu Luyckx, et al.
The Oncologist|February 9, 2017
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal TreatmentPierre Annede, Sébastien Gouy, Renaud Mazeron, et al.
Gynecologic Oncology|September 15, 2015
Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancerPauline Castelnau-Marchand, Cyrus Chargari, Pierre Maroun, et al.
The Oncologist|January 12, 2012
Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancerPhilippe Morice, Philippe Rouanet, Annie Rey, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2020
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancerAlexandra Leary, Catherine Genestie, Félix Blanc-Durand, et al.
Annals of Surgical Oncology|November 7, 2015
Which Surgical Attitude to Choose in the Context of Non-Resectability of Ovarian Carcinomatosis: Beyond Gross Residual Disease ConsiderationsFabien Vidal, Haya Al Thani, Pascale Haddad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie GynécologiqueDenis Querleu, François Planchamp, Fabrice Narducci, et al.
Cancers|June 24, 2022
Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas FranceRita Bentahila, Elie Rassy, Samir Achkar, et al.
Pageof 29

Showing results (231-240 of 284) with videos related to

Sort By:
Pageof 29
Gynecologic Oncology|January 19, 2017
Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factorsAlexandre Escande, Sebastien Gouy, Renaud Mazeron, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2020
Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patientsJean-Baptiste Delhorme, Jordan Ohayon, Sébastien Gouy, et al.
Plos One|January 29, 2016
Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?Fabien Vidal, Paul Guerby, Mathieu Luyckx, et al.
The Oncologist|February 9, 2017
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal TreatmentPierre Annede, Sébastien Gouy, Renaud Mazeron, et al.
Gynecologic Oncology|September 15, 2015
Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancerPauline Castelnau-Marchand, Cyrus Chargari, Pierre Maroun, et al.
The Oncologist|January 12, 2012
Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancerPhilippe Morice, Philippe Rouanet, Annie Rey, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2020
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancerAlexandra Leary, Catherine Genestie, Félix Blanc-Durand, et al.
Annals of Surgical Oncology|November 7, 2015
Which Surgical Attitude to Choose in the Context of Non-Resectability of Ovarian Carcinomatosis: Beyond Gross Residual Disease ConsiderationsFabien Vidal, Haya Al Thani, Pascale Haddad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2011
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie GynécologiqueDenis Querleu, François Planchamp, Fabrice Narducci, et al.
Cancers|June 24, 2022
Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas FranceRita Bentahila, Elie Rassy, Samir Achkar, et al.
Pageof 29